ATE149203T1 - Hybride, lösliche und nicht gespaltene gp160- variante - Google Patents

Hybride, lösliche und nicht gespaltene gp160- variante

Info

Publication number
ATE149203T1
ATE149203T1 AT92910881T AT92910881T ATE149203T1 AT E149203 T1 ATE149203 T1 AT E149203T1 AT 92910881 T AT92910881 T AT 92910881T AT 92910881 T AT92910881 T AT 92910881T AT E149203 T1 ATE149203 T1 AT E149203T1
Authority
AT
Austria
Prior art keywords
hiv
region
strain
soluble
derived
Prior art date
Application number
AT92910881T
Other languages
English (en)
Inventor
Marie-Paule Kieny
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE149203T1 publication Critical patent/ATE149203T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Control Of Vehicle Engines Or Engines For Specific Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT92910881T 1991-05-02 1992-04-30 Hybride, lösliche und nicht gespaltene gp160- variante ATE149203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919105392A FR2676071B1 (fr) 1991-05-02 1991-05-02 Nouveau variant gp160 non-clivable, soluble, de forme hybride.

Publications (1)

Publication Number Publication Date
ATE149203T1 true ATE149203T1 (de) 1997-03-15

Family

ID=9412448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92910881T ATE149203T1 (de) 1991-05-02 1992-04-30 Hybride, lösliche und nicht gespaltene gp160- variante

Country Status (12)

Country Link
US (2) US6261799B1 (de)
EP (1) EP0541753B1 (de)
JP (1) JP3453611B2 (de)
AT (1) ATE149203T1 (de)
CA (1) CA2086509C (de)
DE (1) DE69217614T2 (de)
DK (1) DK0541753T3 (de)
ES (1) ES2099257T3 (de)
FR (1) FR2676071B1 (de)
GR (1) GR3023070T3 (de)
SG (1) SG44828A1 (de)
WO (1) WO1992019742A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677225B2 (en) * 1992-10-06 1997-04-17 Dade Behring Marburg Gmbh Retrovirus from the HIV group and its use
JP3658690B2 (ja) * 1993-01-16 2005-06-08 マンフレート シャヴァラー ウイルスの膜蛋白質の天然ドメインの獲得方法、特にｈｉｖに対するワクチンとしてのそれらの使用
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
NZ520754A (en) 2000-02-10 2004-02-27 Panacos Pharmaceuticals Inc Identifying compounds that disrupt formation of critical gp41 six-helix bundle and conformations necessary for HIV entry thereby blocking virus entry to the cell
WO2009011912A1 (en) * 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
KR102007444B1 (ko) * 2011-04-25 2019-08-06 어드밴스드 바이오사이언스 라보라토리즈, 인코포레이티드 절단형 hiv 피막 단백질(env), 이와 관련된 방법 및 조성물
JP2015522580A (ja) * 2012-07-06 2015-08-06 ノバルティス アーゲー 免疫学的組成物およびその使用
WO2016196471A1 (en) 2015-06-02 2016-12-08 Cooper Human Systems Llc Methods and compositions for treatment of hiv infection
UY37975A (es) * 2017-11-17 2019-02-28 Grifols Diagnostic Solutions Inc Nuevos antigenos de proteinas de la envoltura del virus de la inmunodeficiencia humana (vih) expresados en celulas de mamiferos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
US5169763A (en) * 1986-04-08 1992-12-08 Transgene S.A., Institut Pasteur Viral vector coding glycoprotein of HIV-1
EP0272858A3 (de) * 1986-12-15 1989-07-12 Repligen Corporation Rekombinante HIV-Hüllen-Proteine, hergestellt in Insektenzellen
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
EP0469089B1 (de) * 1989-04-18 1997-11-19 Applied Biotechnology, Inc. Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren
FR2650954B1 (fr) * 1989-08-18 1992-02-28 Pasteur Institut Composition resultant de la reunion d'un epitope b de la glycoproteine d'enveloppe d'un retrovirus du type iv et d'un epitope t issu d'une proteine distincte codee par ce retrovirus et leur application a la production d'anticorps protecteurs contre le sida
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
IE904083A1 (en) * 1989-11-13 1991-05-22 Cambridge Biotech Corp Diagnostic proteins to test for more than one antibody
JP3494300B2 (ja) * 1990-04-03 2004-02-09 ジェネンテック・インコーポレーテッド Ｈｉｖに対する予防接種のための方法および組成物

Also Published As

Publication number Publication date
DK0541753T3 (da) 1997-08-04
FR2676071A1 (fr) 1992-11-06
EP0541753A1 (de) 1993-05-19
CA2086509C (fr) 2003-07-01
GR3023070T3 (en) 1997-07-30
FR2676071B1 (fr) 1994-11-18
CA2086509A1 (fr) 1992-11-03
US6284248B1 (en) 2001-09-04
ES2099257T3 (es) 1997-05-16
SG44828A1 (en) 1997-12-19
EP0541753B1 (de) 1997-02-26
WO1992019742A1 (fr) 1992-11-12
JP3453611B2 (ja) 2003-10-06
US6261799B1 (en) 2001-07-17
DE69217614T2 (de) 1997-07-10
DE69217614D1 (de) 1997-04-03
JPH05508324A (ja) 1993-11-25

Similar Documents

Publication Publication Date Title
DE60037450D1 (de) Funf-helix protein
NO20025153L (no) Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV
DK1240186T3 (da) Forbedringer i eller relateret til immunrespons mod HIV
MY136081A (en) Modified hiv - 1gag p17 peptide and immunogenic composition
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
PT1159298E (pt) Péptidos de hiv, antigénios, composições de vacinas, kit de imunoensaio e um método de detecção de anticorpos induzidos por hiv
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
ATE149203T1 (de) Hybride, lösliche und nicht gespaltene gp160- variante
Nygren et al. 95-and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor.
EP0255190A3 (de) Rekombinante Polypeptide und ihre Verwendungen sowie Test für den AIDS-Virus
DE69231705D1 (de) Gag-Env Fusion-Antigen aus HIV
ES2074591T3 (es) Expresion de polipeptidos de vih 1 y 2 y su utilizacion.
AU8976691A (en) Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof
DK1043974T3 (da) Liposomer indeholdende flergrenede peptidkonstruktioner til anvendelse mod human immundefektvirus
DK0462551T3 (da) Monoklonale antistoffer mod HIV gp120
ES2170161T3 (es) Nuevos conjugados de principios activos y proteinas.
DK284389A (da) Precursorantigener
Giavedoni Developing Novel Conjugate HIV-1 Subunit Therapeutic Vaccines
OA08716A (fr) Peptides susceptibles d'être reconnus par des anticorps induits contre des retrovirus d'immunodéficience humaine (virus HIV), leurs applications au diagnostic des infections dues à certains de ces virus et, le cas échéant, à la vaccination contre le sida.
Ivanoff et al. Human immunodeficiency virus antigen.
HK1028065A1 (en) Peptides for the detection of hiv-1-group o.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification